All
Multiple courses of alefacept safe for psoriasis tx
July 1st 2004Toronto - The biologic medication alefacept (Amevive, Biogen, Inc.) may be safely administered to psoriasis patients in multiple courses as well as in conjunction with other standard therapies, according to a presentation at the 10th International Psoriasis Symposium here.
Chronic HD responds to bexarotene gel
July 1st 2004Portland, OR - In a small study of bexarotene gel treatment for chronic severe hand dermatitis (HD), the medication achieved both speedy and surprising results. In a 55-patient, phase 1-2 open-label randomized clinical study of the gel, used alone and in combination with one of two steroids, 79 percent of patients on monotherapy achieved clinical improvement of at least 50 percent, and 39 percent reached at least 90 percent clearance.
Lasers speed burn healing; diabetics helped most
July 1st 2004Dallas - Laser therapy is gaining acceptance - albeit slowly - as an effective clinical tool for quickening burn healing. Results of a recent study indicate that even for diabetic burn patients, laser therapy may be even more effective than first thought.
GAO urges assistants-at-surgery payment reform
July 1st 2004Key congressional committees with jurisdiction over Medicare have been urged by the General Accounting Office (GAO) to reform the way payments for the services of assistants-at-surgery are made in order to prevent potential abuse and overpayment.
Building your patients' trust: Topical anesthetics are key
July 1st 2004As cosmetic procedures grow in popularity, dermatologists and cosmetic surgeons strive to enhance patient comfort as well as ensure that the entire experience is a pleasant one. Building patient confidence and trust are the ultimate goals, and the use of topical anesthetics has helped greatly toward this end.
Update: Oral Antibiotics in the Treatment of Acne
July 1st 2004Oral antibiotics have an integral role in the treatment of moderate to severe acne. Patient compliance with an acne treatment program is crucial, and those affected must have realistic expectations for treatment. Because many strains of P acnes have become resistant to tetracycline, dermatologists are increasingly turning to doxycycline monohydrate, which has retained efficacy against the organism.
Physician extenders can handle lion's share of ALA-PDT work
June 1st 2004Dallas - What is the nurse's role in the administration of ALA-PDT (5-aminolevulinic acid[ALA]-photodynamic therapy [PDT])? At Gold Skin Care Center in Nashville, the better question might be: What is the physician's role in offering this therapy, which involves the use of a laser or light source plus an enhancer, ALA HCl topical solution, 20 percent, (Levulan, DUSA Pharmaceuticals)?
Cosmeceutical market expanding rapidly while scientific support lags
June 1st 2004Washington - Dermatologists need to keep cosmeceuticals under the magnifying glass and identify the science supporting their efficacy so that they can better advise patients about over-the-counter skincare, said Patricia Farris, M.D., at the annual meeting of the American Academy of Dermatology.
Off-label uses broaden as derms explore Botox
June 1st 2004Washington - The number of potential dermatologic uses for botulinum toxin type A (Botox Cosmetic) continues to increase, but the already sizable list probably only represents the tip of the iceberg, says Seth L. Matarasso, M.D., at the annual meeting of the American Academy of Dermatology